Tuberculosis Elimination in Oman: Winning the War on the Disease

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2018 Dec 13

PMID 30538997

Citations 6

Authors

Salah T Al Awaidy

Affiliations

Soon will be listed here.

Abstract

In 2014, the World Health Assembly adopted the new End TB Strategy that targets ending tuberculosis (TB) by 2035. This article describes the progress made to eliminate TB in Oman. Data from officials and other sources provided the information to assess the situation in Oman. In the period 1981-1992, TB notifications decreased by 11% per year. Between 1992 and 2016, the rates declined more slowly at 4.6% per year, from 16 to 7.8 per 100 000. During 2010-2016, 2352 TB cases (80% males and 60% Omani nationals) were reported. Bacteriologically confirmed TB cases decreased from 47 to 38 per million population, with a cumulative decline of 19%. The success rate of TB treatment was >87%. Among the new cases, 1.2% were multidrug-resistant TB cases. TB mortality rate dropped by 39% between 1990 and 2016. TB control efforts in Oman have produced remarkable effects. However, the pre-elimination threshold set at <10 notified TB cases per million population per year is not yet in reach. There is a need for an urgent national response and careful consideration of new available interventions.

Citing Articles

Epidemiology of tuberculosis in Saudi Arabia following the implementation of end tuberculosis strategy: Analysis of the surveillance data 2015-2019.

Alawi M, Alserehi H, Ali A, Albalawi A, Alanizi M, Nabet F Saudi Med J. 2024; 45(1):60-68.

PMID: 38220236 PMC: 10807673. DOI: 10.15537/smj.2024.45.1.20230424.

Drug resistant in Oman: resistance-conferring mutations and lineage diversity.

Al Mahrouqi S, Gadalla A, Al Azri S, Al-Hamidhi S, Al-Jardani A, Balkhair A PeerJ. 2022; 10:e13645.

PMID: 35919400 PMC: 9339217. DOI: 10.7717/peerj.13645.

Dynamics of Lineages in Oman, 2009 to 2018.

Al-Mahrouqi S, Ahmed R, Al-Azri S, Al-Hamidhi S, Balkhair A, Al-Jardani A Pathogens. 2022; 11(5).

PMID: 35631062 PMC: 9148118. DOI: 10.3390/pathogens11050541.

Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.

Borgio J, Rasdan A, Sonbol B, Alhamid G, Almandil N, AbdulAzeez S Biology (Basel). 2021; 10(11).

PMID: 34827138 PMC: 8614875. DOI: 10.3390/biology10111144.

Retrospective Study of Bone-TB in Oman: 2002-2019.

Hegazy W, Al Mamari R, Almazroui K, Al Habsi A, Kamona A, AlHarthi H J Epidemiol Glob Health. 2021; 11(2):238-245.

PMID: 33969946 PMC: 8242117. DOI: 10.2991/jegh.k.210420.002.

References

Asfour M, Lambourne A, Soliman A, Bold A, Mahtab H, King H . High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey. Diabet Med. 1995; 12(12):1122-5. DOI: 10.1111/j.1464-5491.1995.tb00431.x. View

Fernandez de la Hoz K, Manissero D . A framework action plan to fight tuberculosis in the European Union. Euro Surveill. 2008; 13(12). DOI: 10.2807/ese.13.12.08074-en. View

Jeon C, Murray M . Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7):e152. PMC: 2459204. DOI: 10.1371/journal.pmed.0050152. View

Lonnroth K, Migliori G, Abubakar I, DAmbrosio L, de Vries G, Diel R . Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015; 45(4):928-52. PMC: 4391660. DOI: 10.1183/09031936.00214014. View

Broekmans J, Migliori G, Rieder H, Lees J, Ruutu P, Loddenkemper R . European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands.... Eur Respir J. 2002; 19(4):765-75. DOI: 10.1183/09031936.02.00261402. View

Al-Maniri A, Al-Rawas O, Al-Tuhami H, Eriksson B, Diwan V . Towards the elimination of tuberculosis in a developing country: 25 years of tuberculosis control in Oman. Int J Tuberc Lung Dis. 2007; 11(2):175-80. View

Baker M, Harries A, Jeon C, Hart J, Kapur A, Lonnroth K . The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011; 9:81. PMC: 3155828. DOI: 10.1186/1741-7015-9-81. View

Abdel Aziz M, Baghdadi S, Hajjeh R . What would it take to eliminate tuberculosis in the Eastern Mediterranean Region?. East Mediterr Health J. 2017; 23(6):393-394. View

Al-Lawati J . Diabetes Mellitus: A Local and Global Public Health Emergency!. Oman Med J. 2017; 32(3):177-179. PMC: 5447787. DOI: 10.5001/omj.2017.34. View

10.

. WHO revised definitions and reporting framework for tuberculosis. Euro Surveill. 2013; 18(16):20455. View

11.

Williams B, Granich R, De Cock K, Glaziou P, Sharma A, Dye C . Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A. 2010; 107(45):19485-9. PMC: 2984151. DOI: 10.1073/pnas.1005660107. View

12.

DAmbrosio L, Dara M, Tadolini M, Centis R, Sotgiu G, van der Werf M . Tuberculosis elimination: theory and practice in Europe. Eur Respir J. 2014; 43(5):1410-20. DOI: 10.1183/09031936.00198813. View

13.

Al-Maniri A, Al-Rawas O, Al-Ajmi F, De Costa A, Eriksson B, Diwan V . Tuberculosis suspicion and knowledge among private and public general practitioners: Questionnaire Based Study in Oman. BMC Public Health. 2008; 8:177. PMC: 2413224. DOI: 10.1186/1471-2458-8-177. View

14.

Rendon A, Fuentes Z, Torres-Duque C, Del Granado M, Victoria J, Duarte R . Roadmap for tuberculosis elimination in Latin American and Caribbean countries: a strategic alliance. Eur Respir J. 2016; 48(5):1282-1287. DOI: 10.1183/13993003.01549-2016. View

15.

Khamis F, Al-Lawati A, Al-Zakwani I, Al-Abri S, Al-Naamani J, Al-Harthi H . Latent Tuberculosis in Health Care Workers Exposed to Active Tuberculosis in a Tertiary Care Hospital in Oman. Oman Med J. 2016; 31(4):298-303. PMC: 4927738. DOI: 10.5001/omj.2016.57. View

16.

Al-Maniri A, Fochsen G, Al-Rawas O, De Costa A . Immigrants and health system challenges to TB control in Oman. BMC Health Serv Res. 2010; 10:210. PMC: 2919530. DOI: 10.1186/1472-6963-10-210. View

17.

Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D . Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46(6):1563-76. PMC: 4664608. DOI: 10.1183/13993003.01245-2015. View

18.

Al Awaidy S, Khamis F . Tuberculosis in Gulf Health Council Member States: Opportunities and Challenges Towards TB elimination. Oman Med J. 2018; 33(3):181-183. PMC: 5971058. DOI: 10.5001/omj.2018.35. View

19.

Veen J, Migliori G, Raviglione M, Rieder H, Dara M, Falzon D . Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur Respir J. 2010; 37(4):950-9. DOI: 10.1183/09031936.00019410. View

20.

Yaquobi F, Al-Abri S, Al-Abri B, Al-Abaidani I, Al-Jardani A, DAmbrosio L . Tuberculosis elimination: a dream or a reality? The case of Oman. Eur Respir J. 2018; 51(1). DOI: 10.1183/13993003.02027-2017. View